Zoster Immunoglobulin-VF (CSL Behring)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameZoster Immunoglobulin-VF (CSL Behring)
Drug Alias NameZoster Immunoglobulin-VF
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunoglobulin agonists
TargetsImmunoglobulin
Therapy Area/IndicationsVaricella Zoster Virus Infection
Global Approved IndicationsVaricella Zoster Virus Infection
Approved Indications in ChinaN/A
Original Approved Country/TerritoryAustralia
Original Approved Date2005/04/01
Country/TerritoryNew ZealandAustralia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCsl Behring Llc
China Registration ClassN/A

Develop Information

Active CompaniesCsl Behring Llc
Inactive CompaniesN/A
Active IndicationsVaricella Zoster Virus Infection
Inactive IndicationsN/A

Other Information

ATC CodeJ06BB03
Related LinksN/A